A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

J Med Genet. 2003 Oct;40(10):787-92. doi: 10.1136/jmg.40.10.787.
No abstract available

Publication types

  • Letter

MeSH terms

  • Europe, Eastern / ethnology
  • Founder Effect
  • Gene Frequency
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Predisposition to Disease
  • Humans
  • Israel
  • Jews / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Prostatic Neoplasms* / ethnology
  • Prostatic Neoplasms* / genetics
  • Prostatic Neoplasms* / pathology